Uneingeschränkter Zugang

Endoscopic Mucosal Phenotypes in the Helicobacter Pylori Infection

Geanina Tudor
Geanina Tudor
, 
Roxana Călin
Roxana Călin
, 
Nuta Petrut
Nuta Petrut
, 
Ioniţă Radu Florentina
Ioniţă Radu Florentina
, 
Jinga Mariana
Jinga Mariana
 und 
Bucurică Sandica
Bucurică Sandica
   | 06. Juni 2019
Internal Medicine's Cover Image
Über diesen Artikel
Vorheriger Artikel
Nächster Artikel
Zitieren
Online veröffentlicht: 06. Juni 2019
Seitenbereich: 21 - 32
DOI: https://doi.org/10.2478/inmed-2019-0049
© 2019 Geanina Tudor et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

1. Popa Gabriela Loredana, MI Popa, 2008, Microbiologie Medicala, Editura TipografieSearch in Google Scholar

2. Bȋlbȋe V, Pozsgi N, 1985, Bacteriologie Medicala, vol II, EdituraMedicalaSearch in Google Scholar

3. Boriello P, Murray P, Funke G editors, 2005, Topley and Wilson's Microbiology and Microbial Infections, 10th edition, vol 1 and 2 Bacteriology, Arnold, ASM PressSearch in Google Scholar

4. Buiuc D, 2003, Microbiologie Medicala; Ghid pentru studiul si practica medicinei, editia a VI-a, Editura “Gr.T.Popa”IasiSearch in Google Scholar

5. Buiuc D, Negut M, 1999, Tratat de microbiologie clinica, EdituraMedicalaSearch in Google Scholar

6. Collier Leslie, Albert Balows, Max Sussman editors, 1998, Topley and Wilson's Microbiology and Microbacterial Infections, 9th edition, vol. 3, ArnoldSearch in Google Scholar

7. Dimache G, Panaitescu D, 2004, Bacteriologie, virusologie si parazitologie medicala, Editura Carol DavilaSearch in Google Scholar

8. Mandell GL, Bennett JE, Dolin R, 2005, Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases, 6th ed., vol. 2, Churchill LivingstoneSearch in Google Scholar

9. Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, 1995, Manual of Clinical Microbiology, 6th edition, ASM PressSearch in Google Scholar

10. Murray PR, Rosenthal K, Kobayashi G, Pfaller MA, 2002,Medical Microbiology, 4th ed., Mosby CompanySearch in Google Scholar

11. Fiorini G, Vakil N, Zullo A, Saracino IM, Castelli V, Ricci C, et al. Culture-Based Selection Therapy for Patients Who Did Not Respond to Previous Treatment for Helicobacter pylori Infection. Clin Gastroenterol Hepatol. Dec 23 2012; [Medline].10.1016/j.cgh.2012.12.007Search in Google Scholar

12. Horiki N, Omata F, Uemura M, et al. Annual change of primary resistance to clarithromycin among Helicobacter pylori isolates from 1996 through 2008 in Japan. Helicobacter. Oct 2009;14(5):86-90. [Medline].10.1111/j.1523-5378.2009.00714.xSearch in Google Scholar

13. Fallone CA. Epidemiology of the antibiotic resistance of Helicobacter pylori in Canada. Can J Gastroenterol. Nov 2000;14(10):879-82. [Medline].10.1155/2000/562159Search in Google Scholar

14. Tomb JF, White O, Kerlavage AR, et al. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature. Aug 7 1997;388(6642):539-47. [Medline].10.1038/41483Search in Google Scholar

15. Lowenthal AC, Hill M, Sycuro LK, et al. Functional analysis of the Helicobacter pylori flagellar switch proteins. J Bacteriol. Dec 2009;191(23):7147-56. [Medline]. [Full Text].10.1128/JB.00749-09Search in Google Scholar

16. Giannakis M, Chen SL, Karam SM, et al. Helicobacter pylori evolution during progression from chronic atrophic gastritis to gastric cancer and its impact on gastric stem cells. Proc Natl Acad Sci U S A. Mar 2008;105(11):4358-63. [Medline].10.1073/pnas.0800668105Search in Google Scholar

17. Luther J, Dave M, Higgins PD, Kao JY. Association between Helicobacter pylori infection and inflammatory bowel disease: A meta-analysis and systematic review of the literature. Inflamm Bowel Dis. Sep 16 2009;epub ahead of print. [Medline].10.1002/ibd.21116Search in Google Scholar

18. Jackson L, Britton J, Lewis SA, et al. A populationbased epidemiologic study of Helicobacter pylori infection and i t s association with systemic inflammation. Helicobacter. Oct 2009;14(5):108-13. [Medline].10.1111/j.1523-5378.2009.00711.xSearch in Google Scholar

19. Greenberg ER, Anderson GL, Morgan DR, et al. 14- day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial. Lancet. Aug 6 2011;378(9790):507-14. [Medline].10.1016/S0140-6736(11)60825-8Search in Google Scholar

20. [Best Evidence] Liou JM, Lin JT, Chang CY, et al. Levofloxacin-based and clarithromycin-based triple therapies as first-line and second-line treatments for Helicobacter pylori infection: a randomised comparative trial with crossover design. Gut. May 2010;59(5):572-8. [Medline].10.1136/gut.2009.19830920427390Search in Google Scholar

21. Yoon H, Kim N, Lee BH, et al. Moxifloxacin-containing triplse therapy as second-line treatment for Helicobacter pylori infection: effect of treatment duration and antibiotic resistance on the eradication rate.Helicobacter. Oct 2009;14(5):77-85. [Medline].10.1111/j.1523-5378.2009.00709.x19751431Search in Google Scholar

22. Lee SB, Yang JW, Kim CS. The association between conjunctival MALT lymphoma and Helicobacter pylori. Br J Internal Medicine 2019 vol. XVI No. 1 - www.srmi.ro Ophthalmol. Apr 2008;92(4):534-6. [Medline].10.1136/bjo.2007.13231618369070Search in Google Scholar

23. Aanpreung P. Suggestive parameters for eradication therapy in children with Helicobacter pylori gastritis. JMed Assoc Thai. Nov 2005;88 Suppl 8:S21-6. [Medline].Search in Google Scholar

24. Adachi K, Hashimoto T, Komazawa Y, et al. Helicobacter pylori infection influences symptomatic response to anti-secretory therapy in patients with GORD- -crossover comparative study with famotidine and lowdose lansoprazole. Dig Liver Dis. Jul 2005;37(7):485-90. [Medline].10.1016/j.dld.2004.12.01615975534Search in Google Scholar

25. Alexander GA, Brawley OW. Association of Helicobacter pylori infection with gastric cancer. Mil Med. Jan 2000;165(1):21-7. [Medline].10.1093/milmed/165.1.21Search in Google Scholar

26. Ceponis PJ, Jones NL. Modulation of host cell signal transduction pathways by Helicobacter pylori infection. Can J Gastroenterol. Jul 2005;19(7):415-20. [Medline].10.1155/2005/73181716010303Open DOISearch in Google Scholar

27. Chelimsky G, Czinn SJ. Helicobacter pylori infection in children: update. Curr Opin Pediatr. Oct 2000;12(5):460-2. [Medline].10.1097/00008480-200010000-0000711021411Open DOISearch in Google Scholar

28. Cheng TY, Lin JT, Chen LT, et al. Association of T-cell regulatory gene polymorphisms with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma. J Clin Oncol. Jul 20 2006;24(21):3483-9.[Medline].10.1200/JCO.2005.05.543416849765Open DOISearch in Google Scholar

29. Craanen ME, Blok P, Dekker W, et al. Helicobacter pylori and early gastric cancer. Gut. Oc t 1994;35(10):1372-4. [Medline].10.1136/gut.35.10.137213750077959189Search in Google Scholar

30. Demirel A, Oncel S, Caydere M, et al. Helicobacter pylori infection in gastrectomy specimens. The Internet Journal of Gastroenterology 2000; 1 (1). [Full Text].10.5580/830Search in Google Scholar

31. Dunn BE, Cohen H, Blaser MJ. Helicobacter pylori. Clin Microbiol Rev. Oct 1997;10(4):720-41. [Medline].10.1128/CMR.10.4.7201729429336670Open DOISearch in Google Scholar

32. Eaton KA, Benson LH, Haeger J, et al. Role of transcription factor T-bet expression by CD4+ cells in gastritis due to Helicobacter pylori in mice. Infect Immun. Aug 2006;74(8):4673-84. [Medline].10.1128/IAI.01887-05Search in Google Scholar

33. El-Omar EM, Carrington M, Chow WH, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature. Mar 23 2000;404 (6776):398-402. [Medline].10.1038/35006081Search in Google Scholar

34. Fischbach W. Primary gastric lymphoma of MALT: considerations of pathogenesis, diagnosis and therapy.Can J Gastroenterol. Nov 2000;14 Suppl D:44D-50D. [Medline].10.1155/2000/436854Search in Google Scholar

35. Fock KM, Katelaris P, Sugano K, et al. Second Asia- Pacific Consensus Guidelines for Helicobacter pylori infection.F J Gastroenterol Hepatol. Oct 2009;24(10) :1587-600. [Medline].10.1111/j.1440-1746.2009.05982.xSearch in Google Scholar

36. Freston JW. Management of peptic ulcers: emerging issues. World J Surg. Mar 2000;24(3):250-5.[Medline].10.1007/s002689910040Open DOISearch in Google Scholar

37. Garcia-Altes A, Rota R, Barenys M, et al. Costeffectiveness of a ‘score and scope’ strategy for the management of dyspepsia. Eur J Gastroenterol Hepatol. Jul 2005;17(7):709-19. [Medline].10.1097/00042737-200507000-00004Search in Google Scholar

38. Graham DY. Therapy of Helicobacter pylori: current status and issues. Gastroenterology. Feb 2000;118(2 Suppl 1):S2-8. [Medline].10.1016/S0016-5085(00)70003-5Search in Google Scholar

39. Graham DY, Lew GM, Lechago J. Antral G-cell and Dcell numbers in Helicobacter pylori infection: effect of H. pylori eradication. Gastroenterology. Jun 1993;104(6): 1655-60. [Medline].10.1016/0016-5085(93)90642-PSearch in Google Scholar

40. Nakajima S, Krishnan B, Ota H, et al. Mast cell involvement in gastritis with or without Helicobacter pylori infection. Gastroenterology. Sep 1997;113(3):746-54. [Medline].10.1016/S0016-5085(97)70167-7Search in Google Scholar

eISSN:
1220-5818
Sprache:
Englisch
Zeitrahmen der Veröffentlichung:
4 Hefte pro Jahr
Fachgebiete der Zeitschrift:
Medizin, Klinische Medizin, Allgemeinmedizin, Innere Medizin, andere, Kardiologie, Gastroenterologie, Pneumologie
Zeitschrift RSS Feed